Fabre-Kramer Pharmaceuticals Explained
| Fabre-Kramer Pharmaceuticals |
| Type: | S Corporation |
| Industry: | Pharmaceuticals |
| Founded: | 1992 |
| Founders: | --> |
| Hq Location: | Houston, Texas |
| Areas Served: | --> |
| Key People: | Stephen Kramer (CEO)Ed Koehler (Executive Vice President, CFO) |
| Products: | Travivo (Gepirone ER), FKB01MD, FKW00GA, FKF02SC, FKK01PD |
| Owners: | --> |
| Website: | www.fabrekramer.com |
Fabre-Kramer Pharmaceuticals is a pharmaceutical company that specializes in the development of psychotropic drugs. Products in their current development pipeline include gepirone and FKB01MD for major depression, gepirone and FKW00GA for social anxiety disorder,[1] gepirone for hypoactive sexual desire disorder, FKF02SC for schizophrenia, and FKK01PD for Parkinson's disease.[2]
The company has also conducted clinical studies on a gepirone extended release formulation for major depression.[3] [4] [5]
In 2007, Fabre-Kramer Pharmaceuticals along with GlaxoSmithKline (GSK) received a 'not approvable' letter from the US Food and Drug Administration, for a gepirone extended release drug, an antidepressant treatment for adults.[6]
External links
Notes and References
- Web site: Pipeline – Fabre-Kramer Pharmaceuticals, Inc. . https://web.archive.org/web/20230330232143/https://fabrekramer.com/pipeline/ . March 30, 2023 . 2023-03-30 . en.
- Web site: Product Pipeline . Fabre Kramer Pharmaceuticals . 2011-10-16 . dead . https://web.archive.org/web/20111111164303/http://www.fabrekramer.com/products.html . 2011-11-11 .
- Fabre LF, Smith LC . The Effect of Major Depression on Sexual Function in Women . J Sex Med . 9. 1. 231–9. August 2011 . 21883948 . 10.1111/j.1743-6109.2011.02445.x .
- Fabre LF, Smith LC, DeRogatis LR . Gepirone-ER treatment of low sexual desire associated with depression in women as measured by the DeRogatis Inventory of Sexual Function (DISF) fantasy/cognition (desire) domain--a post hoc analysis . J Sex Med . 8 . 9 . 2569–81 . September 2011 . 21707926 . 10.1111/j.1743-6109.2011.02330.x .
- Fabre LF, Brown CS, Smith LC, Derogatis LR . Gepirone-ER treatment of hypoactive sexual desire disorder (HSDD) associated with depression in women . J Sex Med . 8 . 5 . 1411–9 . May 2011 . 21324094 . 10.1111/j.1743-6109.2011.02216.x .
- Web site: Lewcock . Anna . November 5, 2007 . GSK, Fabre-Kramer lose out on antidepressant . live . https://web.archive.org/web/20230910224559/https://www.outsourcing-pharma.com/Article/2007/11/05/GSK-Fabre-Kramer-lose-out-on-antidepressant . September 10, 2023 . 2020-05-11 . outsourcing-pharma.com . en-GB.
